4[1]Williamson JS.Helicobacter pylori current chemotherapy and new targets for drug design[J].Curr Pharm Des,2001,7(5):355-392.
5[3]Lui SY,Yeoh KG,Ho B,et al.Metronidazole-resistance Helicobacter pylori is more prevalent in patients with nonulcer than peptic ulcer patients in a multiethnic Asian population[J].J Clin Microbiol,2003,41(11):5011-5014.
6[4]Taneike I,Suzuki K,Nakagawa S,et al.Intrafamilial spread of the same clarithromycin-resistance Helicobacter pylori infection confirmed by molecular analysis[J].J Clin Microbiol,2004,42(8):3901-3903.
7Malat y H M, El-Kasabany A, Graham DY. et al. Age at acquisition of Helicobacter pylori infection:a follow-up study from infancy to adulthood[J], Lancet,2002,359(3) :931- 935.
8Nabwera HM,Nguyen VanTam JS,Logan RF,et al. Prewalcnce of Helicobaeter pylori infection in Kenyan school children aged 3 15 years and risk factors for infection[J]. Eur J Gastrocnterol Hepatol,2000,12(2) :483 -487.
9Granquist A, Bredberg A, Sweger T, et al. A lougiludinal cohort study on the prevalence of Helicobacter pylori antibodies in Swed-ish children and adolescents[J]. Acta Paediatr, 2002,91 ( 3) : 636 -640.
10Lin DB,Nieh WT,Wang HM.et al. Seroepidemiology of Helico batter pylori infection among preschool children in Taiwan[ J]. Am J Trop Med Hyg,1999,61(3):554-558.
